Hims & Hers Health Inc’s filing revealed that its Chief Financial Officer Okupe Oluyemi unloaded Company’s shares for reported $0.26 million on Jun 25 ’24. In the deal valued at $22.21 per share,11,546 shares were sold. As a result of this transaction, Okupe Oluyemi now holds 177,449 shares worth roughly $3.8 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Boughton Soleil sold 2,335 shares, generating $51,790 in total proceeds. Upon selling the shares at $22.18, the Chief Legal Officer now owns 171,479 shares.
Before that, Chi Michael sold 17,303 shares. Hims & Hers Health Inc shares valued at $381,877 were divested by the Chief Commercial Officer at a price of $22.07 per share. As a result of the transaction, Chi Michael now holds 185,326 shares, worth roughly $3.97 million.
Citigroup downgraded its Hims & Hers Health Inc [HIMS] rating to a Neutral from a a Buy in a research note published on May 22, 2024; the price target was increased to $20 from $16. A number of analysts have revised their coverage, including Jefferies’s analysts, who decreased its forecast for the stock in mid April from “a Buy” to “a Hold”. Canaccord Genuity began covering HIMS with “Buy” recommendation on April 10, 2024. Imperial Capital revised its rating on February 28, 2024. It rated HIMS as “an Outperform” which previously was an “an In-line”.
Price Performance Review of HIMS
On Monday, Hims & Hers Health Inc [NYSE:HIMS] saw its stock jump 6.09% to $21.42. Over the last five days, the stock has lost -3.30%. Hims & Hers Health Inc shares have risen nearly 140.67% since the year began. Nevertheless, the stocks have risen 135.64% over the past one year. While a 52-week high of $25.74 was reached on 06/18/24, a 52-week low of $5.65 was recorded on 01/05/24. SMA at 50 days reached $17.42, while 200 days put it at $11.49. A total of 8.69 million shares were traded, compared to the trading of 20.71 million shares in the previous session.
Levels Of Support And Resistance For HIMS Stock
The 24-hour chart illustrates a support level at 20.58, which if violated will result in even more drops to 19.74. On the upside, there is a resistance level at 21.87. A further resistance level may holdings at 22.32. The Relative Strength Index (RSI) on the 14-day chart is 53.55, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.02, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 62.25%. Stochastics%K at 25.12% indicates the stock is a holding.
The most recent change occurred on February 26, 2024 when Leerink Partners began covering the stock and recommended ‘”a Market perform”‘ rating along with a $10 price target.
